Cargando…
The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms
BACKGROUND: In clinics, patients with type 2 diabetes complicated with non-alcoholic fatty liver disease (NAFLD) have been shown to receive significant improvements in blood glucose levels, lipid levels, and liver function after sitagliptin treatment, although the mechanism of drug action remains po...
Autores principales: | Xu, Bilin, Shen, Tian, Chen, Lin, Xia, Juan, Zhang, Cuiping, Wang, Hongping, Yu, Ming, Lei, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370388/ https://www.ncbi.nlm.nih.gov/pubmed/28315901 http://dx.doi.org/10.12659/MSM.900033 |
Ejemplares similares
-
Functional Dissection of CD26 and Its Pharmacological Inhibition by Sitagliptin During Skin Wound Healing
por: Jiang, Yue, et al.
Publicado: (2021) -
Intermittent Fasting Improves Lipid Metabolism Through Changes in Gut Microbiota in Diet-Induced Obese Mice
por: Deng, Ya, et al.
Publicado: (2020) -
Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022) -
Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease
por: Jiang, Jie, et al.
Publicado: (2021) -
Pathogenesis of Abnormal Hepatic Lipid Metabolism Induced by Chronic Intermittent Hypoxia in Rats and the Therapeutic Effect of N-Acetylcysteine
por: Wang, Haipeng, et al.
Publicado: (2018)